Disclosure Of Interests In Other Entities [Text Block]

PCI Biotech Holding - Filing #5867918

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	30 905 NOK	—	—	—	—	—	43 753 NOK	—	—
Non-current assets	—	—	310,000 NOK	—	—	—	—	—	297,000 NOK	—	—
Current liabilities	—	—	7 762 NOK	—	—	—	—	—	4 974 NOK	—	—
Non-current liabilities	—	—	- NOK	—	—	—	—	—	34,000 NOK	—	—
Profit (loss)	16 417 NOK	- NOK	—	16 417 NOK	- NOK	- NOK	20 315 NOK	20 315 NOK	—	- NOK	—
Comprehensive income	16 417 NOK	- NOK	—	16 417 NOK	- NOK	- NOK	20 315 NOK	20 315 NOK	—	- NOK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	- NOK	- NOK	—	- NOK	- NOK	- NOK	- NOK	- NOK	—	- NOK	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	27 069 NOK	—	—	—	—	—	41 184 NOK	—	56 596 NOK
Tax expense (income)	- NOK	—	—	—	—	—	—	- NOK	—	—	—